Show more
This leaflet answers some common questions about LACT-FREE MEDICINE.
The information provided should not be used as a substitute for your medical advice.
Ask your doctor or pharmacist to review this leaflet.
You may refer to any of the information this leaflet contains.
To learn more about LACT-FREE MEDICINE, see the contents on the booklet.
You may also consult a doctor or pharmacist.
LACT-FREE (lactose-free non-steroidal anti-inflammatory drugs) is used in adults and children to treat symptoms of pain, inflammation, swelling, and stiffness and relieve symptoms of an inflamed pain in the knee. It is also used to treat pain from the following:
• Joint pain and swelling (inflammation of the joints) in adults and children
• Pain from inflammation of the ligaments, muscles and tendons
• Joint injury
The recommended dose is one 2.5mg tablet taken once a day for 7 days. If you are taking other anti-inflammatory medicines, you may take it up to 4 weeks before pain begins.
The effects of LACT-FREE medicines can last up to 7 days.
If this does not help, you may not need to take it.
Your doctor may give you a reduced dose.
LACT-FREE tablets contain the following inactive ingredients: lactose monohydrate, magnesium stearate, sodium lauryl sulfate, titanium dioxide, and lactose.
The active ingredient in LACT-FREE tablets is lactose-free.
The usual dose of LACT-FREE tablets is one 2.5mg tablet taken once a day for 7 days.
LACT-FREE tablets contain the following inactive ingredients: lactose monohydrate, magnesium stearate, titanium dioxide, and lactose.
Do not take LACT-FREE tablets if you are allergic to lactose (or any of the other ingredients listed at the end of this leaflet).
Lactose can pass through broken or non-YE absorbable clothing and mucus. If you are not sure you can take LACT-FREE tablets, talk to your doctor or pharmacist before taking this medicine.
Some medicines may make LACT-FREE tablets difficult to swallow or take for a number of reasons, including:
• It may irritate the stomach or intestines
• You may be sick (such as a bad asthma attack)
• Lactose-containing products do not protect you
• The medicine contains lactose.
Talk to your doctor before taking this medicine if:
• You have severe kidney problems
• You are over 65 years of age
• You have an irregular heartbeat
• You have bleeding or bruising
Lactose-containing medicines may cause diarrhea or stomach bleeding. If you or your doctor notice these symptoms, tell your doctor as soon as possible.
Other side effects of LACT-FREE tablets may include stomach pain, feeling sick (stomachache), diarrhoea and rash. Lactose-containing medicines, or LACT-FREE tablets, may also help to reduce the effects of certain blood-sugar medicines, such as dihydroergotamine, loratidine, orexinin, sumatriptan, and so on.
Lactose-containing medicines may make it more difficult to swallow LACT-FREE tablets. To see if this is an issue, ask a pharmacist.
Actos 30 mg tablet contains an active ingredient called pioglitazone. It belongs to the family known as ‘3 generation’ drugs. It is a special drug group. Actos is used for the treatment of type 2 diabetes mellitus (non-insulin-dependent diabetes, not requiring daily insulin use). This medicine is also for use in the treatment of cardiovascular diseases, including high blood pressure, atherosclerosis (red- colored blood vessels), and other cardiovascular conditions. It is also used in the treatment of some other conditions, such as high blood pressure, high cholesterol, prostate cancer, high blood cholesterol levels, and atherosclerosis. Actos is used as a hypertension treatment and as a lowering agent.
Do not take Actos if you are allergic to pioglitazone, ezetimix or any of its ingredients. Do not take this medicine if you are allergic to any of the following ingredients: any other anti-diabetic medicine, including medicines used to treat weight loss, such as phentermine and diethylpropion (Eskalith, Dietrich, Mitigoster) and medicines used to treat HIV/AIDS, including nelfinavir and ritonavir. Talk to your doctor or pharmacist before taking this medicine if you are pregnant or breast-feeding
Before taking this medicine, tell your doctor if you have any liver problems, kidney problems, or heart problems (such as heart failure or heart attack). Tell your doctor if you are pregnant or plan to become pregnant or breast-feeding. Do not take Actos if you are breast-feeding.
The active ingredient in Actos, pioglitazone, belongs to a family of medicines called 3 generation drugs. This group of drugs is used mostly in adults and children. Pioglitazone is available in the form of tablets, capsules, ointments and solutions. Pioglitazone tablets and Pioglitazone ointment are available in the form of oral suspension, chewable tablets and oral tablet. Pioglitazone tablets and Pioglitazone tablets disintegrate under high pressure and is absorbed into the body rapidly. Pioglitazone ointment also has a low risk of gastrointestinal side effects. Pioglitazone tablets are not a diuretic and are not an effective treatment for high blood pressure or high blood cholesterol levels.
Actos can be used in the treatment of type 2 diabetes mellitus (non-insulin-dependent diabetes, not requiring daily insulin use). It also is used for the treatment of cardiovascular diseases, including high blood pressure, atherosclerosis (red- colored blood vessels), and other cardiovascular conditions. Actos is also used for the treatment of high blood pressure levels and high cholesterol levels in people with high blood pressure who are at high risk for a heart attack or stroke, or who have high cholesterol levels.
The medicine in this drug group is known by the brand names Diabetic and Mitioglitazone. It is also used for the treatment of heart failure and diabetic cardiomyopathy.
This group of drugs is often used in the treatment of type 1 diabetes mellitus (non-insulin-dependent diabetes, not requiring daily insulin use). Actos is also used as a lowering agent.
Side effects of Actos may include severe kidney problems, breast-feeding or pregnant/pregnant patients, vomiting, diarrhea, constipation, abdominal pain, dizziness, lightheadedness, headache, flushing and dizziness. Talk to your doctor if you are using any of the following medicines.
It can take 1 to 2 weeks before your symptoms improve. However, if you do not notice any improvement within 1 week, tell your doctor. Do not stop taking this medicine without consulting your doctor.
This medicine is not recommended for use in children. Consult your doctor before using Actos if you are pregnant or breastfeeding.
The most common side effects of Actos are headaches, dizziness, lightheadedness, vision changes (such as blurring), irregular heartbeat and skin rash. If any of the side effects bother you, discuss other treatment options with your doctor. Your doctor will probably prescribe a different medicine.
Read More What You DoTake Actos 30 mg tablet by mouth with or without food as directed by your doctor, usually once or twice daily. Take the medicine at the same time every day. Swallow the tablet whole, with or without food. Do not chew or crush the tablets. If your symptoms worsen, contact your doctor.
Do not take Actos for more than 1 year.
A retrospective observational cohort study of doxycycline treatment in patients with uncomplicated or complicated intra-abdominal infection (ICA) showed a higher incidence of antibiotic-associated malignancies compared to untreated ICA. The present study aimed to assess the association of doxycycline use and malignancy in the setting of an uncomplicated ICA and to identify factors associated with an increased risk of malignancy.
In a population-based retrospective cohort study of adult patients with ICA, the incidence of malignancies was determined by age, sex, and comorbidity, in patients with ICA treated for a median of 12.5 months in the period between 2012 and 2019. Malignancies were identified by the authors as the first- or the second-line of therapy in ICA patients, based on the definition of ICA as ‘prophylactic malignancy’ (WHO). The number of malignancies was determined by the International Society of Anesthesiologists (ISAA) and the American Society of Anesthesiologists (ASA) in 2015. The following risk factors for malignancies have been identified in the literature: a history of ICA, current/exacerbation of ICA, previous malignancy and other conditions (eg, pelvic inflammatory disease, or malignancy after surgical resection). The risk factors for malignancies were determined by the following subgroup criteria: the following: sex, comorbidity, and family history of malignancy: ‘high risk’; ‘low risk’; ‘exceeding risk’.
The current guidelines recommend a dose of 100 mg of doxycycline per day for uncomplicated or complicated ICA in adult patients. This regimen was considered to be a reasonable option for patients with complicated ICA due to the high success rates of treatment with doxycycline in this population, and there is currently no evidence to suggest that this dose is associated with an increased risk of malignancies.
The current guidelines suggest that the dose is not to exceed 200 mg once daily for patients with complicated ICA.
In a retrospective study of patients with complicated intra-abdominal infection, the incidence of malignancies was determined by the International Society of Anesthesiologists (ISAA) as the first- or the second-line of therapy in ICA patients. The proportion of malignancies in patients with complicated ICA ranged from 0 to 8% (Table ). The present study aimed to assess the association between doxycycline use and malignancy in the setting of complicated ICA and to identify factors associated with an increased risk of malignancy.
A retrospective observational cohort study was conducted at the Department of Microbiology, University of Texas Southwestern Medical School, San Antonio, USA, between 2012 and 2019. The study was conducted in accordance with the Declaration of Helsinki, and was approved by the institutional review board of San Antonio, USA, and the Institutional Review Board of the University of Texas Southwestern Medical School, San Antonio, USA.
The study population consisted of patients aged ≥20 years diagnosed with complicated intra-abdominal infection (CUI) who were admitted for treatment of ICA. The patients were excluded if they had previously undergone surgery or had an infection with Gram-negative bacteria and had any previous malignancies. The patients were followed at least annually through the completion of a prospective observational cohort study of patients with CUI.
A retrospective observational cohort study was conducted from 2013 to 2019 in patients with CUI who were treated at the Department of Microbiology, University of Texas Southwestern Medical School, San Antonio, USA, between 2012 and 2019. The study population consisted of patients aged ≥20 years diagnosed with complicated intra-abdominal infection (CUI) who were treated with either doxycycline 100 mg/day or oral doxycycline 100 mg/day.
The study population was also included if they had a history of malignancy after the diagnosis of CUI. The patients were excluded if they had a history of malignancy in their primary care or if they had a diagnosis of CUI by the World Health Organization (WHO). The study population was defined as patients who were hospitalized for ICA in the emergency department.
For the treatment of Type 2 Diabetes in adults, it is important to follow the recommendations of your healthcare provider. The recommended dose of Actos for the treatment of Type 2 Diabetes is 15 mg per day. It is important to take Actos once a day, as it can affect the absorption of the medication. This can be taken with or without food. Follow the dosage instructions provided by your healthcare provider and follow them when starting Actos. It is not recommended to take it for longer than four hours without speaking to your healthcare provider. You should also discuss the potential risks and benefits of Actos before taking it. It is also important to note that Actos should not be taken with grapefruit juice, as it may interact with it. It is also important to discuss with your healthcare provider about any other medications you are taking before starting Actos. If you are concerned about any medication, please contact your healthcare provider if you are taking any of the following:
Stade de France Pharmacy